Literature DB >> 24507951

A simple versatile solution for collecting multidimensional clinical data based on the CakePHP web application framework.

Martin Biermann1.   

Abstract

Clinical trials aiming for regulatory approval of a therapeutic agent must be conducted according to Good Clinical Practice (GCP). Clinical Data Management Systems (CDMS) are specialized software solutions geared toward GCP-trials. They are however less suited for data management in small non-GCP research projects. For use in researcher-initiated non-GCP studies, we developed a client-server database application based on the public domain CakePHP framework. The underlying MySQL database uses a simple data model based on only five data tables. The graphical user interface can be run in any web browser inside the hospital network. Data are validated upon entry. Data contained in external database systems can be imported interactively. Data are automatically anonymized on import, and the key lists identifying the subjects being logged to a restricted part of the database. Data analysis is performed by separate statistics and analysis software connecting to the database via a generic Open Database Connectivity (ODBC) interface. Since its first pilot implementation in 2011, the solution has been applied to seven different clinical research projects covering different clinical problems in different organ systems such as cancer of the thyroid and the prostate glands. This paper shows how the adoption of a generic web application framework is a feasible, flexible, low-cost, and user-friendly way of managing multidimensional research data in researcher-initiated non-GCP clinical projects.
Copyright © 2014 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  CakePHP; Clinical Data Management System; Investigator-initiated clinical research; PHP; Web application framework

Mesh:

Year:  2014        PMID: 24507951     DOI: 10.1016/j.cmpb.2014.01.007

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  6 in total

1.  Assessing Extraprostatic Extension with Multiparametric MRI of the Prostate: Mehralivand Extraprostatic Extension Grade or Extraprostatic Extension Likert Scale?

Authors:  Lars A R Reisæter; Ole J Halvorsen; Christian Beisland; Alfred Honoré; Karsten Gravdal; Are Losnegård; Jan Monssen; Lars A Akslen; Martin Biermann
Journal:  Radiol Imaging Cancer       Date:  2020-01-17

2.  Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity.

Authors:  Martin Biermann; Jostein Kråkenes; Katrin Brauckhoff; Hans Kristian Haugland; Achim Heinecke; Lars A Akslen; Jan Erik Varhaug; Michael Brauckhoff
Journal:  Acta Radiol       Date:  2015-03-13       Impact factor: 1.990

3.  F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis.

Authors:  Torjan Haslerud; Katrin Brauckhoff; Lars Reisæter; Regina Küfner Lein; Achim Heinecke; Jan Erik Varhaug; Martin Biermann
Journal:  Acta Radiol       Date:  2015-07-09       Impact factor: 1.990

4.  E-learning for medical imaging specialists: introducing blended learning in a nuclear medicine specialist course.

Authors:  Torjan Haslerud; Andreas Julius Tulipan; Robert M Gray; Martin Biermann
Journal:  Acta Radiol Open       Date:  2017-07-25

5.  EMG changes during continuous intraoperative neuromonitoring with sustained recurrent laryngeal nerve traction in a porcine model.

Authors:  Katrin Brauckhoff; Turid Aas; Martin Biermann; Paul Husby
Journal:  Langenbecks Arch Surg       Date:  2016-04-16       Impact factor: 3.445

6.  Optimising preoperative risk stratification tools for prostate cancer using mpMRI.

Authors:  Lars A R Reisæter; Jurgen J Fütterer; Are Losnegård; Yngve Nygård; Jan Monssen; Karsten Gravdal; Ole J Halvorsen; Lars A Akslen; Martin Biermann; Svein Haukaas; Jarle Rørvik; Christian Beisland
Journal:  Eur Radiol       Date:  2017-10-06       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.